Results 251 to 260 of about 466,856 (291)
Some of the next articles are maybe not open access.
New classes of glaucoma medications
Current Opinion in Ophthalmology, 2017To discuss recent advances in the medical management of glaucoma and to highlight future medical therapies currently in development.In 1996, latanoprost (Xalatan) was approved in the United States as a new chemical entity and new class (prostaglandin analogs) for the topical treatment of ocular hypertension and glaucoma.
Emily M, Schehlein +2 more
openaire +2 more sources
Benzalkonium Chloride in Glaucoma Medications
The Ocular Surface, 2011Benzalkonium chloride (BAK) is the preservative used most commonly in eye drops. Although it is effective as an antimicrobial and antifungal agent, both in vitro and in vivo studies have demonstrated adverse effects on surface epithelial cell populations.
Robert, Noecker, Kimberly V, Miller
openaire +2 more sources
Cost Analysis of Glaucoma Medications
American Journal of Ophthalmology, 2008To provide patients and health care providers with calculated yearly costs of topical glaucoma medications.Prospective, experimental, laboratory study.Using the average wholesale price and common dosing patterns, we calculated the theoretical yearly cost of glaucoma medications.Calculated yearly cost ranged from $150.81 for generic timolol maleate 0.5%
Nathan R, Rylander, Steven D, Vold
openaire +2 more sources
Medical therapy for glaucoma: A review
Clinical & Experimental Ophthalmology, 2022AbstractA number of pharmacological targets are exploited to modify the parameters in the Goldmann equation and reduce the intraocular pressure (IOP). This strategy constitutes the foundation for the medical management of glaucoma, the evolution of which, until only recently, has been in relative stagnation.
openaire +2 more sources
Insight (American Society of Ophthalmic Registered Nurses), 2013
Glaucoma is a common eye condition that affects millions of individuals worldwide, making it the second-leading cause of blindness. Because glaucoma is associated with increased IOP level, the primary goal in treatment of glaucoma includes lowering IOP to prevent further progression of the disease.
Bora, Chae +2 more
openaire +1 more source
Glaucoma is a common eye condition that affects millions of individuals worldwide, making it the second-leading cause of blindness. Because glaucoma is associated with increased IOP level, the primary goal in treatment of glaucoma includes lowering IOP to prevent further progression of the disease.
Bora, Chae +2 more
openaire +1 more source
Perspectives in the medical treatment of glaucoma
Current Opinion in Ophthalmology, 1999Many advances in medical therapy for chronic glaucoma have taken place in the past few years that have altered previous concepts of stepwise medical therapy for glaucoma. beta-adrenergic blockers are still the most common medicine prescribed as monotherapy.
openaire +2 more sources
Medical treatment of glaucoma: present and future
Expert Opinion on Investigational Drugs, 2011In the last decades, the therapy of glaucoma has largely shifted from surgery to medical treatment thanks to the introduction of strongly effective formulations, that is, prostaglandin analogs and fixed combinations. This clinical scenario may dramatically change in the future thanks to the progresses in biochemistry, genetics and drug delivery ...
P. Fogagnolo, L. Rossetti
openaire +2 more sources
MEDICAL TREATMENT OF ACUTE GLAUCOMA
Archives of Ophthalmology, 1946It is certainly a curious, but explicable, fact that by living constantly in the presence of a difficulty man becomes less apt to overcome it. —Prof. Dr. Charles Nicolle. 1 SELDOM do oculists encounter in the exercise of their profession a more dramatic scene than that of an acute attack of glaucoma.
openaire +2 more sources
Medical Management of Glaucoma
International Ophthalmology Clinics, 2008Casey C, Geringer, Nauman R, Imami
openaire +2 more sources
[Medical management of glaucoma and interaction between glaucoma and systemic medications].
Laeknabladid, 2019Glaucoma used to be the most common cause for blindness in Iceland. As the incidence of glaucoma increases with age, the patients often have numerous comorbidities and use various medications. It is important to keep in mind interactions and side effects of glaucoma medications when deciding systemic medical treatment for these patients to ensure their
Valgerdur Dora, Traustadottir +4 more
openaire +1 more source